Thrivent High Yield Fund outperforms benchmark in 2025

The Thrivent High Yield Fund (LBHIX) achieved an 8.72% return in 2025, surpassing the Bloomberg US Corporate High Yield Bond Index's 8.62% performance. This outperformance was driven by declining high-yield spreads and Treasury yields. The fund's strategy focused on credit selection in specific industries amid a healthy economic outlook.

The Thrivent High Yield Fund delivered strong results for the year ending December 31, 2025, outperforming its benchmark, the Bloomberg US Corporate High Yield Bond Index, which returned 8.62%. The fund's return of 8.72% was supported by a decline in both high-yield spreads and Treasury yields, contributing to positive market conditions.

For the quarterly and one-year periods ending on that date, the Thrivent High Yield Fund exceeded the index's performance. Key contributors included effective credit selection in the midstream, retail, and packaging sectors, which generated positive relative returns throughout the year.

Looking ahead, the fund maintains a short duration stance and is modestly underweight in the lowest quality segment of the market. Although most economic and market indicators suggest a healthy outlook, the commentary notes that spreads are at decade lows, which moderates expectations for further gains.

This performance reflects the fund's strategic positioning in a favorable environment for high-yield bonds.

Связанные статьи

The Lord Abbett Intermediate Tax Free Fund achieved a 1.61% return in the fourth quarter of 2025, surpassing its benchmark. This performance was driven by strategic positioning in the yield curve. The broader municipal bond market also saw positive returns amid significant inflows throughout the year.

Сообщено ИИ

The John Hancock Global Shareholder Yield Fund achieved a positive return in the fourth quarter of 2025, surpassing its benchmark, the MSCI World Index. Stock selections in the information technology and financials sectors drove the fund's strong performance. The fund aims to provide a high level of income alongside some capital appreciation.

The Harbor International Compounders Fund (HSICX) returned 3.19% in the fourth quarter of 2025, underperforming its benchmark, the MSCI All Country World ex-US Index, which gained 5.05%. Key holdings like AstraZeneca and SSE contributed positively to performance. The fund made several portfolio adjustments, including new purchases and sales of positions.

Сообщено ИИ

The Fidelity Small Cap Growth Fund (FCPGX) gained 3.16% in the fourth quarter of 2025, surpassing the Russell 2000 Growth Index's 1.22% advance. This performance was driven by key holdings like Cogent Biosciences.

 

 

 

Этот сайт использует куки

Мы используем куки для анализа, чтобы улучшить наш сайт. Прочитайте нашу политику конфиденциальности для дополнительной информации.
Отклонить